Department of Biotechnology, Ministry of Science & Technology, Govt. of India-Global AMR R&D Hub partnership


The Department of Biotechnology, Ministry of Science & Technology, Government of India announce that India through Department of Biotechnology, Ministry of Science & Technology has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new Member. This expands the global partnership working to address challenges and improve coordination and collaboration in global AMR R&D to 16 countries, the European Commission, two philanthropic foundations and four international organisations (as observers).

The Global AMR R&D Hub was launched in May 2018 in the margins of the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017. The Global AMR R&D Hub supports global priority setting and evidence-based decision-making on the allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration and leveraging in AMR R&D. The operation of the Global AMR R&D Hub is supported through a Secretariat, established in Berlin and currently financed through grants from the German Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Health (BMG).

From this year onward India will be the member of Board of members of Global AMR R&D Hub. By partnering with the Global AMR R&D Hub, India looks forward to working with all partners to leverage their existing capabilities, resources and collectively focus on new R&D intervention to address drug resistant infections. The emergence and spread of antimicrobial resistance continues unabated around the world. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, it is reasonable to explore issues of antimicrobial resistance through the lens of One Health approach and should be supported by long-term commitments from all stakeholders.
Through this, all participating countries, organizations and philanthropic foundations will have a role to play to protect the efficacy of antimicrobial agents and to support the efforts of the different sectors at national, regional and global levels. Working together, AMR challenges can be well addressed and further inevitable changes can be delineated in the trajectory of health for humanity.”

The acting Chair of the Global AMR R&D Hub Board of Members, Bersabel Ephrem, Director General of the Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada said:
“I am very pleased to welcome India as an important addition to our global partnership. Addressing AMR requires global action with active participation from all world regions and One Health sectors. Expanding the membership of the Hub works towards ensuring that different countries needs are incorporated when considering AMR R&D activities and actions.” In a major boost to combat one of the gravest risks to global health a dedicated special vehicle in terms of Global AMR R&D Hub may allow partners to devote expertise in order to accelerate global action against antimicrobial resistance.


About Author

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Leave A Reply